Advanced Medical Pricing Solutions (AMPS) Acquires Drexi

WP Global Partners Invests in Advanced Medical Pricing Solutions (AMPS)

November 12, 2021

Healthcare Services

On November 12, 2021, WP Global Partners made a growth investment in Advanced Medical Pricing Solutions (AMPS). AMPS provides claim review and repricing services and healthcare payment-integrity SaaS and tech-enabled solutions for self-insured employers and health plans to lower overall healthcare costs.

Cimarron Healthcare Capital, RAF Industries and Leavitt Equity Partners Recapitalize Advanced Medical Pricing Solutions (AMPS)

May 10, 2022

Healthcare Services

Cimarron Healthcare Capital led an investor group including RAF Industries and Leavitt Equity Partners in a recapitalization of Advanced Medical Pricing Solutions (AMPS) to support the company's growth and expansion. Debt financing was provided by Oxford Finance and Webster Bank, financial terms were not disclosed, and AMPS's original shareholders and management will retain significant ownership and remain in place.

Alliance Pharma (Ampersand-backed) Acquires LGC's Drug Development Solutions; KKR Joins as Equal Shareholder

May 17, 2022

Healthcare Services

Alliance Pharma, an Ampersand-backed US bioanalytical CRO, acquired Drug Development Solutions (DDS), LGC’s UK-based bioanalytical and materials science testing business. Ampersand Capital Partners and KKR will be equal shareholders in the combined business to expand geographic reach, broaden laboratory capabilities, and extend the service portfolio internationally.

EPAM Systems Acquires Deltix

March 20, 2020

Software

EPAM Systems, Inc. has acquired Deltix, Inc. and will form a real-time computing lab to provide a center of excellence for real-time event processing and analytics focused on capital markets, crypto trading, IoT and signal processing. Deltix will continue to serve systematic and algorithmic trading clients while EPAM integrates Deltix's technology across its FinTech practice and broader industry practices.

AMSYS Group Acquires HealthConnexx

February 14, 2020

Data & Analytics

AMSYS Group, a Houston-based healthcare technology and IT services firm, has acquired Virginia-based HealthConnexx, maker of the RxConnexx real-time medication data exchange platform. The acquisition bolsters AMSYS's healthcare technology portfolio by adding HealthConnexx's data-as-a-service capabilities—providing real-time medication and benefits data to providers, payers, pharmacies and other stakeholders.

Ampersand Capital Partners Majority Recapitalizes Phosphorex

August 25, 2022

Healthcare Services

Ampersand Capital Partners completed a majority recapitalization of Phosphorex to provide growth capital enabling the company to build out a 30,000 sq. ft. facility and establish cGMP manufacturing capabilities for lipid nanoparticles, microspheres and other drug-delivery platforms. The investment positions Phosphorex to expand from development and analytical services into end-to-end CDMO manufacturing to better serve pharmaceutical and biotechnology clients.